首页> 外文期刊>Toxicon: An International Journal Devoted to the Exchange of Knowledge on the Poisons Derived from Animals, Plants and Microorganisms >The role of indomethacin and tezosentan on renal effects induced by Bothrops moojeni Lys49 myotoxin I
【24h】

The role of indomethacin and tezosentan on renal effects induced by Bothrops moojeni Lys49 myotoxin I

机译:吲哚美辛和替佐生在Bothrops moojeni Lys49肌毒素I诱导的肾功能中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Renal changes determined by Lys49 myotoxin I (BmTx I), isolated from Bothrops moojeni are well known. The scope of the present study was to investigate the possible mechanisms involved in the production of these effects by using indomethacin (10mug/mL), a non-selective inhibitor of cyclooxygenase, and tezosentan (10mug/mL), an endothelin antagonist. By means of the method of mesenteric vascular bed, it has been observed that B. moojeni myotoxin (5mug/mL) affects neither basal perfusion pressure nor phenylephrine-preconstricted vessels. This fact suggests that the increase in renal perfusion pressure and in renal vascular resistance did not occur by a direct effect on renal vasculature. Isolated kidneys from Wistar rats, weighing 240-280g, were perfused with Krebs-Henseleit solution. The infusion of BmTx-I increased perfusion pressure, renal vascular resistance, urinary flow and glomerular filtration rate. Sodium, potassium and chloride tubular transport was reduced after addition of BmTx-I. Indomethacin blocked the effects induced by BmTx-I on perfusion pressure and renal vascular resistance, however, it did not revert the effect on urinary flow and sodium, potassium and chloride tubular transport. The alterations of glomerular filtration rate were inhibited only at 90min of perfusion. The partial blockade exerted by indomethacin treatment showed that prostaglandins could have been important mediators of BmTx-I renal effects, but the participation of other substances cannot be excluded. The blockage of all renal alterations observed after tezosentan treatment support the hypothesis that endothelin is the major substance involved in the renal pathophysiologic alterations promoted by the Lys49 PLA(2) myotoxin I, isolated from B. moojeni. In conclusion, the rather intense renal effects promoted by B. moojeni myotoxin-I were probably caused by the release of renal endothelin, interfering with the renal parameters studied.
机译:众所周知,从Bothrops moojeni分离出的Lys49肌毒素I(BmTx I)确定了肾脏变化。本研究的范围是研究通过使用吲哚美辛(10 ug / mL)(一种非选择性的环氧合酶抑制剂)和替佐生坦(10 ug / mL)(一种内皮素拮抗剂)来产生这些效应的可能机制。通过肠系膜血管床的方法,已经观察到moojeni B. myotoxin(5mug / mL)既不影响基础灌注压力也不影响苯肾上腺素收缩的血管。这一事实表明,对肾脏血管系统没有直接影响,不会导致肾脏灌注压力和肾脏血管阻力的增加。用Krebs-Henseleit溶液灌注从Wistar大鼠分离出的重240-280g的肾脏。输注BmTx-1会增加灌注压力,肾血管阻力,尿流和肾小球滤过率。加入BmTx-1后,钠,钾和氯化物的管状转运减少。吲哚美辛阻断了BmTx-1诱导的对灌注压和肾血管阻力的作用,但并未逆转对尿流以及钠,钾和氯化物肾小管运输的作用。肾小球滤过率的改变仅在灌注90分钟时被抑制。吲哚美辛治疗所产生的部分阻断作用表明,前列腺素可能是BmTx-1肾效应的重要介体,但不能排除其他物质的参与。替佐生坦治疗后观察到的所有肾脏改变均受阻,支持以下假设:内皮素是从B. moojeni分离得到的Lys49 PLA(2)肌毒素I促进的肾脏病理生理改变的主要物质。总之,由穆氏乙型肌毒素-I促进的相当强烈的肾脏作用可能是由于肾内皮素的释放引起的,干扰了所研究的肾脏参数。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号